Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Syngene International Ltd. ( (IN:SYNGENE) ) has provided an update.
Syngene International Limited has launched a ‘100 Days Campaign’ called ‘Saksham Niveshak’ to encourage shareholders to update their KYC and bank details and claim any unpaid or unclaimed dividends before they are transferred to the Investor Education and Protection Fund (IEPF). This initiative, in response to a directive from the Ministry of Corporate Affairs, aims to ensure shareholders receive their entitled dividends and maintain transparency in financial transactions, reflecting the company’s commitment to shareholder engagement and regulatory compliance.
More about Syngene International Ltd.
Syngene International Limited operates in the biotechnology industry, providing integrated research, development, and manufacturing services. The company focuses on delivering innovative solutions to pharmaceutical, biotechnology, and agrochemical sectors, enhancing its market presence through strategic collaborations and cutting-edge technology.
Average Trading Volume: 44,224
Technical Sentiment Signal: Sell
Current Market Cap: 258.2B INR
See more insights into SYNGENE stock on TipRanks’ Stock Analysis page.